Benaroya Research Institute Welcomes New Board Member for 2016

Seattle, WA
01/27/2016

Jeffrey WortleyBenaroya Research Institute at Virginia Mason (BRI) announced a new member to its Board of Directors: Jeffrey Wortley.

Jeffrey Wortley is Market Manager for Key Private Banking Seattle-Cascade offices. He provides customized financial strategies to meet the long term goals of families, business owners and nonprofit organizations. Wortley has more than 25 years’ experience in the financial services industry. He was previously a wealth management consultant with UBS working with clients throughout the Pacific Northwest. He is currently a member of the Seattle Estate Planning Council and Finance Co-Chair for the Seattle Chamber of Commerce.

Benaroya Research Institute at Virginia Mason (BRI) is committed to finding causes and cures for autoimmune diseases such as type 1 diabetes, rheumatoid arthritis, inflammatory bowel disease and multiple sclerosis, and immune system diseases such as allergies and asthma.  An internationally-recognized medical research institute, BRI accelerates discovery through laboratory breakthroughs in immunology that are then translated to clinical therapies.  BRI is a leader of collaborative initiatives through the Immune Tolerance Network, Type 1 Diabetes TrialNet and other major cooperative research programs.  Visit BenaroyaResearch.org or follow Benaroya Research Institute on Facebook to learn more.

Media Contact:

Kay Branz
Director, Marketing Communications & External Relations
kbranz@benaroyaresearch.org / 206-342-6903

Learn the Latest

A sample printed newsletterSign up for our news & updates and learn the latest in the fight against autoimmune diseases.

Sign up today